Recombinant UPF0098 protein Mb1946c (Mb1946c)

What is Recombinant UPF0098 protein Mb1946c?

Recombinant UPF0098 protein Mb1946c is a protein derived from Mycobacterium bovis that belongs to the UPF0098 protein family. The "UPF" designation refers to "Uncharacterized Protein Family," indicating that the precise function of this protein has not been fully elucidated. When expressed as a recombinant protein, Mb1946c can be produced in heterologous expression systems such as E. coli, yeast, baculovirus, or mammalian cells . The recombinant form typically includes affinity tags (His, GST, or FLAG) to facilitate purification and detection in experimental systems.

What organism does Mb1946c originate from?

Mb1946c is natively expressed in Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex. M. bovis is primarily known as the causative agent of bovine tuberculosis but can also infect humans and other mammals. Mycobacterium species are characterized as slender, slightly curved bacterial cells that can be classified into three main groups: Mycobacterium tuberculosis complex, non-tuberculous mycobacteria, and Mycobacterium avium . Understanding the taxonomic context is essential for researchers investigating potential functional homologs across related species.

What is the UPF0098 protein family?

The UPF0098 protein family consists of several uncharacterized proteins found across different bacterial species. According to available data, this family includes numerous members such as:

• UPF0098 protein AF_1698

• UPF0098 protein aq_1250

• UPF0098 protein CPn_0877/CP_0992/CPj0877/CpB0906

• UPF0098 protein CT_736

• UPF0098 protein Mb1945c

• UPF0098 protein Mb2164c

• UPF0098 protein MT1961

• UPF0098 protein MT2198

These proteins likely share sequence and structural similarities, suggesting potential conserved functions across different bacterial species despite their currently uncharacterized status.

What expression systems are commonly used for recombinant Mb1946c production?

Multiple expression systems have been validated for the production of recombinant Mb1946c, including E. coli, yeast, baculovirus, and mammalian cell systems . Each system offers distinct advantages:

The choice of expression system should be guided by specific experimental requirements, including protein folding needs, post-translational modification requirements, and downstream applications.

What strategies optimize expression of soluble Mb1946c in E. coli?

For proteins traditionally difficult to purify, such as Mb1946c, low basal expression levels often facilitate proper folding and increase solubility compared to overexpression approaches. Research indicates that instead of dramatically overproducing target proteins, controlled expression at lower levels can significantly enhance correct folding and solubility . Implementation strategies include:

• Vector selection: Use vectors with moderate-strength promoters or tightly regulated expression systems

• Temperature optimization: Expression at reduced temperatures (16-20°C) after induction

• Inducer concentration: Reduced IPTG concentrations (0.1-0.2 mM) for T7-based systems

• Co-expression approaches: Addition of molecular chaperones (GroEL/GroES, DnaK/DnaJ)

• Fusion partners: N-terminal fusion with solubility enhancers (MBP, SUMO, GST)

This approach has been successfully applied to difficult-to-purify proteins including human DNA polymerases η, ι, and ν, resulting in catalytically active enzymes .

How can optimal experimental design principles be applied to Mb1946c functional studies?

Optimal experimental design for Mb1946c functional studies can be approached using D-Bayes methodology based on mutual information and submodularity principles . This framework is particularly valuable when working with uncharacterized proteins where experimental outcomes are uncertain. The approach involves:

• Formulating the experimental design problem with clearly defined objectives

• Determining controllable experimental parameters based on mutual information and submodularity

• Measuring informative values associated with each choice of experimental design

• Learning a correction function based on measured informative values

• Combining experimental design setup with settings to construct an improved model

The objective is to configure experimental parameters to minimize uncertainty in model predictions following measurements, compared to pre-measurement uncertainty. This approach maximizes information gain while optimizing resource utilization, avoiding the prohibitive computational complexity of exhaustive search methods .

What purification strategy yields the highest purity for recombinant Mb1946c?

Based on protocols developed for similar challenging proteins, a multi-step purification approach is recommended for recombinant Mb1946c:

• Initial capture:

  • Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

  • Glutathione-Sepharose chromatography for GST-fusion proteins

  • Anti-FLAG affinity chromatography for FLAG-tagged proteins

• Secondary purification:

  • Ion-exchange chromatography (anion or cation exchange depending on protein pI)

  • Hydrophobic interaction chromatography

• Polishing step:

  • Size-exclusion chromatography for final purification and buffer exchange

For consistently difficult-to-purify proteins, specialized expression vectors have been developed that facilitate correct folding during expression, potentially eliminating the need for refolding procedures . These vectors express proteins at controlled basal levels rather than inducing overexpression, which has proven successful for challenging proteins including DNA polymerases.

How can the structural integrity of purified Mb1946c be verified?

Structural integrity verification for purified Mb1946c should employ multiple complementary techniques:

For recombinant proteins with historical purification challenges, it's particularly important to verify that the purified protein maintains its native conformation before proceeding to functional studies .

What controls should be included in Mb1946c expression and purification experiments?

Robust experimental design for Mb1946c studies requires carefully selected controls:

• Expression controls:

  • Empty vector control (same vector without Mb1946c gene)

  • Non-induced culture containing the Mb1946c expression construct

  • Well-characterized protein expressed under identical conditions

  • Time-course sampling to optimize induction period

• Purification controls:

  • Starting material (clarified lysate) sample for yield calculations

  • Flow-through from affinity chromatography to verify binding efficiency

  • Wash fractions to monitor potential target protein loss

  • Elution fractions to assess purity and recovery

• Analytical controls:

  • Known protein standards for quantification

  • Tagged protein standards for Western blot analysis

  • Previous successful Mb1946c preparation (if available)

  • Related UPF0098 family proteins for comparative analysis

These controls help discriminate between issues specific to Mb1946c and general experimental problems, facilitating troubleshooting and optimization.

How can researchers design experiments to identify Mb1946c binding partners?

Designing experiments to identify binding partners for an uncharacterized protein like Mb1946c requires a strategic approach based on optimal experimental design principles :

• Primary screening methods:

  • Pull-down assays using affinity-tagged Mb1946c

  • Co-immunoprecipitation with anti-tag antibodies

  • Bacterial two-hybrid or yeast two-hybrid screening

  • Proximity-dependent biotin identification (BioID)

• Validation techniques:

  • Reciprocal pull-downs with identified partners

  • Surface plasmon resonance for kinetic measurements

  • Microscale thermophoresis for quantitative binding analysis

  • ELISA-based interaction assays

• Experimental design considerations:

  • Apply mutual information principles to identify the most informative experimental conditions

  • Use submodularity to select a subset of experiments that maximizes information gain

  • Design experiments that can correct for model misspecification

  • Implement iterative experimental cycles, where each round is informed by previous results

This framework provides a systematic approach to interaction studies that maximizes information content while minimizing experimental resources.

What strategies can address challenges in Mb1946c solubility and stability?

Addressing solubility and stability challenges for Mb1946c requires a multifaceted approach:

• Expression-level strategies:

  • Low basal expression rather than overexpression to promote proper folding

  • Co-expression with molecular chaperones to assist folding

  • Expression as fusion proteins with solubility enhancers

  • Codon optimization for the expression host

• Buffer optimization:

  • Systematic screening of buffer conditions (pH, ionic strength)

  • Addition of stabilizing agents (glycerol, arginine, sucrose)

  • Inclusion of reducing agents if the protein contains cysteines

  • Testing mild detergents or surfactants at low concentrations

• Storage considerations:

  • Determination of optimal protein concentration for storage

  • Identification of appropriate storage temperature

  • Evaluation of freeze-thaw stability

  • Assessment of lyophilization as a preservation method

For particularly challenging proteins, the strategy described in search result of expressing at lower levels to facilitate proper folding may be more effective than traditional approaches that focus on maximizing expression.

How can researchers determine optimal conditions for functional assays of Mb1946c?

Since Mb1946c belongs to an uncharacterized protein family, determining conditions for functional assays requires a systematic approach:

• Bioinformatic analysis:

  • Sequence analysis for conserved motifs suggesting function

  • Structural prediction to identify potential active sites

  • Phylogenetic analysis to find characterized homologs

• Buffer condition screening:

  • pH optimization (typically range 5.5-8.5)

  • Salt concentration (50-500 mM)

  • Divalent cation requirements (Mg²⁺, Mn²⁺, Ca²⁺, Zn²⁺)

  • Reducing environment requirements

• Experimental design application:

  • Apply D-Bayes optimal design to maximize information gain

  • Design experiments with controllable parameters based on mutual information

  • Learn from each experimental iteration to refine conditions

• Activity assessment metrics:

  • Enzymatic activity measurements if catalytic function is suspected

  • Binding assays for potential ligands or protein partners

  • Structural changes upon potential substrate binding

  • Thermal stability shifts in the presence of ligands

This methodical approach, coupled with optimal experimental design principles, provides the most efficient path to functional characterization of this uncharacterized protein.

What are common issues encountered during Mb1946c expression and how can they be resolved?

Researchers working with challenging proteins like Mb1946c often encounter specific expression issues. Common problems and solutions include:

The strategy of expressing proteins at low basal levels rather than inducing overexpression has proven successful for numerous difficult-to-purify proteins, including human DNA polymerases .

How can researchers validate antibodies for Mb1946c detection in immunological studies?

Comprehensive antibody validation for Mb1946c studies should include:

• Specificity validation:

  • Western blot against purified recombinant Mb1946c

  • Testing against lysates from expression systems with and without Mb1946c

  • Cross-reactivity assessment against related UPF0098 family proteins

  • Peptide competition assays to confirm epitope specificity

• Application-specific validation:

  • For Western blotting: Determination of optimal antibody dilution and detection conditions

  • For immunoprecipitation: Quantification of pull-down efficiency

  • For immunofluorescence: Verification of signal specificity using knockdown or knockout controls

• Documentation requirements:

  • Catalog number and lot information

  • Complete validation data for specific applications

  • Optimal working concentrations and conditions

  • Confirmed epitope information when available

For Mb1946c specifically, antibodies against common tags (His, GST, FLAG) can be useful for detection of recombinant versions , while specific antibodies against the native protein would require rigorous validation.

What approaches can researchers use to characterize potential enzymatic activity of Mb1946c?

Characterizing potential enzymatic activity of uncharacterized proteins like Mb1946c requires a systematic approach:

• Bioinformatic prediction:

  • Sequence analysis for conserved catalytic motifs

  • Structural modeling to identify potential active sites

  • Comparison with characterized enzymes in similar families

• Screening strategies:

  • Activity-based protein profiling with mechanism-based probes

  • Substrate panels based on predicted activity class

  • Coupled enzymatic assays with detection systems

  • Metabolite profiling in cells with modulated Mb1946c expression

• Experimental design implementation:

  • Apply D-Bayes optimal experimental design principles

  • Design experiments to test multiple hypotheses simultaneously

  • Use mutual information metrics to prioritize the most informative assays

  • Implement iterative cycles of experimentation with model correction

• Validation approaches:

  • Site-directed mutagenesis of predicted catalytic residues

  • Inhibitor studies if activity is detected

  • Comparative analysis with related UPF0098 family members

  • Structural studies to confirm substrate binding sites

This comprehensive approach combines computational prediction, systematic experimental design, and rigorous validation to efficiently characterize potential enzymatic functions.

How can researchers develop a structure-function relationship model for Mb1946c?

Developing a structure-function relationship model for Mb1946c involves integrating multiple experimental approaches:

• Structural characterization:

  • X-ray crystallography or cryo-EM for high-resolution structure

  • NMR spectroscopy for dynamic regions and ligand interactions

  • Small-angle X-ray scattering for solution structure

  • Molecular modeling when experimental structures are unavailable

• Functional mapping:

  • Alanine scanning mutagenesis of conserved residues

  • Domain deletion or truncation analysis

  • Chimeric protein construction with related UPF0098 family members

  • Point mutations based on structural insights

• Correlation analysis:

  • Mapping functional data onto structural models

  • Evolutionary conservation analysis across species

  • Comparison with characterized proteins sharing structural features

  • Molecular dynamics simulations to understand conformational changes

• Experimental design optimization:

  • Apply mutual information principles to select the most informative mutations

  • Use submodularity to design efficient experimental sets

  • Implement iterative experimental cycles guided by emerging data

This integrated approach efficiently builds a structure-function relationship model while minimizing experimental resources through optimal experimental design principles.

What are promising research areas for further characterization of Mb1946c function?

Future research directions for Mb1946c characterization should focus on several complementary approaches:

• Comprehensive comparative genomics:

  • Analysis of gene neighborhood conservation across mycobacterial species

  • Co-expression network analysis to identify functional associations

  • Evolutionary analysis of UPF0098 family members across bacterial taxa

• Advanced structural biology:

  • High-resolution structural determination through X-ray crystallography or cryo-EM

  • Structural comparison with characterized proteins across bacterial species

  • Fragment-based screening to identify potential ligands or substrates

• Systems biology approaches:

  • Transcriptomic and proteomic profiling in knockout or overexpression models

  • Metabolomic analysis to identify pathways affected by Mb1946c modulation

  • Network analysis to position Mb1946c within mycobacterial cellular processes

• Experimental design innovation:

  • Application of mutual information and submodularity principles to maximize research efficiency

  • Development of high-throughput screening approaches for potential functions

  • Implementation of machine learning to integrate diverse experimental datasets

These approaches, particularly when guided by optimal experimental design principles, offer the most promising path toward elucidating the biological role of this uncharacterized protein.